One thing has become painfully obvious, after Friday's consumer price index reading came in at a scorching 8.6% year over year, the highest reading since 1981.
AbbVie could report extremely high growth rates for revenue and earnings per share since 2013. While analysts are rather pessimistic, management is expecting high-single-digit growth rates after 2025.
Should investors be keeping an eye on these movers in the biotech space?

7 Dividend Stocks to Buy for Your Grandkids

06:43am, Saturday, 11'th Jun 2022
If this roiling market is making you seasick, then it's an excellent time batten down the hatches with these reliable dividend stocks. The post 7 Dividend Stocks to Buy for Your Grandkids appeared fir
AbbVie has generated outstanding returns for shareholders while paying out a hefty dividend that has been growing rapidly. Much of this success was due to the wildly profitable best-selling drug Humir
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. Institutions hold 71% of shares, insiders less than 1%, and dividends yield some 4% yearly. Prior price range foreca
Shares of AbbVie have been performing well over the last decade as the company grew both sales and EPS. AbbVie shares are not expensive at the moment and the company has significant growth opportuniti
Investors looking for passive income from holding stocks should consider these dividend stocks that offer strong payouts. The post 3 Dividend Stocks to Buy Now for 20 Years of Income Growth appeared f

Could AbbVie Stock Help You Retire a Millionaire?

07:45am, Wednesday, 08'th Jun 2022
As long as you're not in a hurry, yes.
It probably wasn't a very good fit for his investing preferences in the first place.
AbbVie recently shared encouraging clinical trial results for patients taking Rinvoq to treat Crohn's disease.
Bigger is not always better, but it does not hurt.
Christopher Raymond, Piper Sander senior biotech analyst, joins 'Power Lunch' to discuss what it means for biotech companies to be defensive, Raymond's thoughts around Abbvie and if biotech companies
Dr. Scott Gottlieb, former FDA commissioner and CNBC contributor, joins CNBC's 'Squawk Box' to discuss the top drug trial data coming out of the American Society of Clinical Oncology conference in Ch
In the history of the United States, there have been a handful of true visionaries that changed life and the world as we know it.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE